Cargando…

The parasitic worm product ES-62 protects the osteoimmunology axis in a mouse model of obesity-accelerated ageing

Despite significant increases in human lifespan over the last century, adoption of high calorie diets (HCD) has driven global increases in type-2 diabetes, obesity and cardiovascular disease, disorders precluding corresponding improvements in healthspan. Reflecting that such conditions are associate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harnett, Margaret M., Doonan, James, Lumb, Felicity E., Crowe, Jenny, Damink, Roel Olde, Buitrago, Geraldine, Duncombe-Moore, Josephine, Wilkinson, Debbie I., Suckling, Colin J., Selman, Colin, Harnett, William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465317/ https://www.ncbi.nlm.nih.gov/pubmed/36105811 http://dx.doi.org/10.3389/fimmu.2022.953053

Ejemplares similares

Protection Against Arthritis by the Parasitic Worm Product ES-62, and Its Drug-Like Small Molecule Analogues, Is Associated With Inhibition of Osteoclastogenesis
por: Doonan, James, et al.
Publicado: (2018)

Dendritic cells provide a therapeutic target for synthetic small molecule analogues of the parasitic worm product, ES-62
por: Lumb, Felicity E., et al.
Publicado: (2017)

The parasitic worm product ES-62 promotes health- and life-span in a high calorie diet-accelerated mouse model of ageing
por: Crowe, Jenny, et al.
Publicado: (2020)

The parasitic worm product ES-62 normalises the gut microbiota bone marrow axis in inflammatory arthritis
por: Doonan, James, et al.
Publicado: (2019)

Suppression of inflammatory arthritis by the parasitic worm product ES-62 is associated with epigenetic changes in synovial fibroblasts
por: Corbet, Marlene, et al.
Publicado: (2021)

Site-specific glycoproteomic characterization of ES-62: The major secreted product of the parasitic worm Acanthocheilonema viteae
por: North, Simon J, et al.
Publicado: (2019)

Development of Acanthocheilonema viteae in Meriones shawi: Absence of microfilariae and production of active ES‐62
por: Lumb, Felicity E., et al.
Publicado: (2020)

Failure of the Anti-Inflammatory Parasitic Worm Product ES-62 to Provide Protection in Mouse Models of Type I Diabetes, Multiple Sclerosis, and Inflammatory Bowel Disease
por: Doonan, James, et al.
Publicado: (2018)

Small Molecule Analogues of the parasitic worm product ES-62 interact with the TIR domain of MyD88 to inhibit pro-inflammatory signalling
por: Suckling, Colin J., et al.
Publicado: (2018)

Testing small molecule analogues of the Acanthocheilonema viteae immunomodulator ES‐62 against clinically relevant allergens
por: Janicova, L., et al.
Publicado: (2016)

Drug-like analogues of the parasitic worm-derived immunomodulator ES-62 are therapeutic in the MRL/Lpr model of systemic lupus erythematosus
por: Rodgers, D T, et al.
Publicado: (2015)

The role of individual protein kinase C isoforms in mouse mast cell function and their targeting by the immunomodulatory parasitic worm product, ES-62
por: Bell, Kara S., et al.
Publicado: (2015)

The Parasitic Worm Product ES-62 Targets Myeloid Differentiation Factor 88–Dependent Effector Mechanisms to Suppress Antinuclear Antibody Production and Proteinuria in MRL/lpr Mice
por: Rodgers, David T, et al.
Publicado: (2015)

The parasitic worm-derived immunomodulator, ES-62 and its drug-like small molecule analogues exhibit therapeutic potential in a model of chronic asthma
por: Coltherd, J. C., et al.
Publicado: (2016)

Designing Anti-inflammatory Drugs from Parasitic Worms: A Synthetic Small Molecule Analogue of the Acanthocheilonema viteae Product ES-62 Prevents Development of Collagen-Induced Arthritis
por: Al-Riyami, Lamyaa, et al.
Publicado: (2013)

Protective effect of small molecule analogues of the Acanthocheilonema viteae secreted product ES-62 on oxazolone-induced ear inflammation
por: Al-Riyami, Lamyaa, et al.
Publicado: (2015)

IL-33/ST2 signalling and crosstalk with FcεRI and TLR4 is targeted by the parasitic worm product, ES-62
por: Ball, Dimity H., et al.
Publicado: (2018)

Small molecule analogues of the immunomodulatory parasitic helminth product ES-62 have anti-allergy properties
por: Rzepecka, Justyna, et al.
Publicado: (2014)

Lessons from helminth infections: ES-62 highlights new interventional approaches in rheumatoid arthritis
por: Pineda, M A, et al.
Publicado: (2014)

Protection against collagen-induced arthritis in mice afforded by the parasitic worm product, ES-62, is associated with restoration of the levels of interleukin-10-producing B cells and reduced plasma cell infiltration of the joints
por: Rodgers, David T, et al.
Publicado: (2014)

Mast Cell Subsets and Their Functional Modulation by the Acanthocheilonema viteae Product ES-62
por: Ball, Dimity H., et al.
Publicado: (2013)

Prophylactic and therapeutic treatment with a synthetic analogue of a parasitic worm product prevents experimental arthritis and inhibits IL-1β production via NRF2-mediated counter-regulation of the inflammasome
por: Rzepecka, Justyna, et al.
Publicado: (2015)

A novel therapeutic approach to cytokine modulation in articular inflammation using filarial nematode derived ES-62
por: McInnes, IB, et al.
Publicado: (2003)

ES‐62 Protects Against Collagen‐Induced Arthritis by Resetting Interleukin‐22 Toward Resolution of Inflammation in the Joints
por: Pineda, Miguel A., et al.
Publicado: (2014)

The helminth product, ES-62, protects against airway inflammation by resetting the Th cell phenotype
por: Rzepecka, Justyna, et al.
Publicado: (2013)

The Carbohydrate-linked Phosphorylcholine of the Parasitic Nematode Product ES-62 Modulates Complement Activation
por: Ahmed, Umul Kulthum, et al.
Publicado: (2016)

The helminth product, ES-62 modulates dendritic cell responses by inducing the selective autophagolysosomal degradation of TLR-transducers, as exemplified by PKCδ
por: Eason, Russell J., et al.
Publicado: (2016)

Osteoimmunology and osteoporosis
por: Geusens, Piet, et al.
Publicado: (2011)

Osteoimmunology and Beyond
por: Ginaldi, Lia, et al.
Publicado: (2016)

Osteoimmunology of Spondyloarthritis
por: Fassio, Angelo, et al.
Publicado: (2023)

Osteoimmunology - Unleashing the concepts
por: Murthy, M. Bhanu
Publicado: (2011)

Osteoimmunology in rheumatic diseases
por: Schett, Georg
Publicado: (2009)

Osteoimmunology in Bone Regeneration
por: Li, Ziqing, et al.
Publicado: (2020)

Editorial: Advances in Osteoimmunology
por: Blin-Wakkach, Claudine, et al.
Publicado: (2019)

The Role of Osteoimmunology in Periodontal Disease
por: Kayal, Rayyan A.
Publicado: (2013)

Osteoimmunology: A Brief Introduction
por: Greenblatt, Matthew B., et al.
Publicado: (2013)

Interferon-Gamma-Mediated Osteoimmunology
por: Tang, Mengjia, et al.
Publicado: (2018)

Rheumatoid Arthritis in the View of Osteoimmunology
por: Auréal, Mélanie, et al.
Publicado: (2020)

Osteoimmunology and osteonecrosis of the femoral head
por: Ma, Maoxiao, et al.
Publicado: (2022)

Brugia malayi Antigen (BmA) Inhibits HIV-1 Trans-Infection but Neither BmA nor ES-62 Alter HIV-1 Infectivity of DC Induced CD4(+) Th-Cells
por: Mouser, Emily E. I. M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_oo92odiualm90tk2bl016e4uio